Breaking limits in bioanalysis

Client
  • PROJECT DELIVERY
FOx BIOSYSTEMS
  • 2021
06 Jun 2022

Breaking limits in bioanalysis

The client FOx BIOSYSTEMS is a dynamic company on a mission to revolutionize the life science and pharmacological research markets with innovative real-time, label-free analysis products based on surface plasmon resonance. The challenge We were challenged to produce a fresh new look and corporate message, which we incorporated into a set of new communication assets,…
06 Jun 2022

Unmatched genetic solutions

The client Cergentis developed the widely published Targeted Locus Amplification (TLA) technology, a next-generation sequencing (NGS) technology offering unique advantages in the implementation of precision medicine and advanced genetic engineering. The challenge Cergentis were planning to release products in a new application area and were looking for a way to fine-tune their branding and communication…
06 Jun 2022

Watching over you

The client CardiacSense is a validated medical wearable which is easy to use for the home monitoring of a number of vital bio-parameters. A large amount of high-quality clinical data is collected about the patient in a non-invasive way, 24/7. This data can support doctors in making a diagnosis, while at the same time proving useful for prevention.…
06 Jun 2022

The health cluster of Wallonia

The client BioWin is the Health Cluster of Wallonia, Belgium, representing all Walloon stakeholders in innovative research projects in health biotechnology and medical technologies and providing them with business development services and communication support.  The challenge BioWin wanted to update their branding and create a dynamic new website to celebrate their 15-year anniversary. See how…
06 May 2022

Automated cell culture monitoring

The client Ovizio Imaging Systems is an image-based sensor company transforming cell culture monitoring with innovative patented microscopy solutions. They produce microscopes that are driven by machine learning to support scientists and biomanufacturers when scaling up their cell- & gene-based therapeutics and vaccine development & manufacturing. The challenge Ovizio wanted a new website and various…
06 Mar 2022

Microbe-based pharmaceutical agents

The client ActoBio Therapeutics™ is pioneering a new class of safe, effective and easy-to-use treatments called ActoBiotics™ for autoimmune and allergic disorders based on the well-characterized food-grade bacterium Lactococcus lactis. The challenge ActoBio asked us to create a new brand identity and associated assets to communicate their scientific breakthroughs. Play product video play_arrow Play company…